Advertisement

Topics

Upside Biotechnologies Company Profile

15:25 EST 15th December 2018 | BioPortfolio

The company’s technology enables a small sample of unburnt patient skin to be grown in the laboratory into large areas of full thickness skin. This lab-grown skin can be used as skin grafts in patients with major burns who do not have enough uninjured skin to provide conventional skin grafts. Upside skin is produced faster than any competitive product in development. It is supplied in larger sheets with excellent handling characteristics preferred by burns surgeons.


News Articles [224 Associated News Articles listed on BioPortfolio]

DGAP-Stimmrechte: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Elanix Biotechnologies AG Elanix Biotechnologies AG: Veröf...

DGAP-Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG / Ve.....

Deals this week: SQZ Biotechnologies, Immugenyx, Berkeley Lights

SQZ Biotechnologies has expanded its collaboration with Roche to develop products for oncology indications using cellular therapy. The two companies...Read More... The post Deals this week: SQZ Biotec...

DGAP-Adhoc: Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied (deutsch)

Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied DGAP-Ad-hoc: Elanix Biotechnologies AG / Schlagwort(e): Personalie Elanix Biotechnologies A...

DGAP-Adhoc: Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an (deutsch)

Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an DGAP-Ad-hoc: Elanix Biotechnologies AG / Sc....

INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES

$35.00End Date: Friday Aug-3-2018 5:25:47 PDTBuy It Now for only: $35.00Buy It Now | Add to watch list Biotech365 : INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES BioMarketplace You want to p...

Elanix Biotechnologies: Erfolgreiche Finanzierungsrunde

Ende Mai hat Elanix Biotechnologies eine Kapitalerhöhung angekündigt, heute kommt die Vollzugsmeldung der Berliner. Die Gesellschaft hat fast 0,68 Millionen Aktien ausgegeben. Der Bezugspreis je Ak....

Hoverink Biotechnologies, Inc., today announced that they have completed an application with the USPTO for MAXKAFLEN®. Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic.

Overview LOS ANGELES, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- On September 26, 2018 We filed trademark applications covering: MAXKAFLEN® Word Mark               MAXKAFLEN Goods and...

Drugs and Medications [22 Associated Drugs and Medications listed on BioPortfolio]

Kolorz [Medical Products Laboratories, Inc.]

kolorz Sixty Second Fluoride Foam Cherry Cheesecake

Kolorz [Medical Products Laboratories, Inc.]

kolorz Sixty Second Fluoride Foam Cotton Candy

Kolorz [Medical Products Laboratories, Inc.]

kolorz Sixty Second Fluoride Foam Triple Mint

Kolorz [Medical Products Laboratories, Inc.]

kolorz Sixty Second Fluoride Foam Blue Raspberry

Saline mist [Rebel Distributors Corp]

Saline Mist Drug Facts

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

No added sugar: antibody makers find an upside to 'no fucose'.

From the Editors' Desk: Truth Rules, or the Upside of Bureaucracy.

With CMS Demanding More Accountability in the MSSP, Will It Be 'ACOs Overboard'?

For 169 ACOs, time is up to take on downside risk. This group-30% of all of those in the Medicare Shared Savings Program (MSSP)-are Track 1, upside risk-only ACOs and are nearing the end of their cont...

Biological sulfur oxidation in wastewater treatment: A review of emerging opportunities.

Sulfide prevails in both industrial and municipal waste streams and is one of the most troublesome issues with waste handling. Various technologies and strategies have been developed and used to deal ...

High-throughput optimisation of light-driven microalgae biotechnologies.

Microalgae biotechnologies are rapidly developing into new commercial settings. Several high value products already exist on the market, and systems development is focused on cost reduction to open up...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Effect of Modified 45-degree Head-up Tilt Position in Cesarean Operation to the Success of Spinal Anesthesia

The success of the application of spinal block in 3 different application as the sitting position, side decubitus position and 45 degrees head upside side decubitus position will be evalua...

Upside Down, Give me the Handle

In schizophrenia, dislocation of psychic functions involving a loss of contact with reality is frequently found. A fragmentation of motor and sensory perceptions could be held responsible ...

Improving Quality and Consistency in Family Education Prior to First Discharge Following Pediatric Cancer Diagnosis

When a child is diagnosed with cancer the family's world is turned upside down. Parents have high levels of stress because they must learn important information about their child's diagnos...

Companies [107 Associated Companies listed on BioPortfolio]

Upside Biotechnologies

The company’s technology enables a small sample of unburnt patient skin to be grown in the laboratory into large areas of full thickness skin. This lab-grown skin can be used...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

NEXGEN Biotechnologies, Inc.

NEXGEN Biotechnologies, Inc. is the specialized 2nd Generation Plant Biotechnology company begun firstly in Korea.NEXGEN Biotechnologies, Inc., established in November 1999, is the venture biotechnolo...

More Information about "Upside Biotechnologies" on BioPortfolio

We have published hundreds of Upside Biotechnologies news stories on BioPortfolio along with dozens of Upside Biotechnologies Clinical Trials and PubMed Articles about Upside Biotechnologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Upside Biotechnologies Companies in our database. You can also find out about relevant Upside Biotechnologies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...


Corporate Database Quicklinks



Searches Linking to this Company Record